We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Study to Determine Racial and Gender Differences in Platelet Aggregation

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00233428
First Posted: October 5, 2005
Last Update Posted: May 12, 2015
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
Texas Tech University Health Sciences Center
  Purpose
The purpose of this study is to see if there is a racial and/or gender difference in platelet aggregation.

Condition Intervention Phase
Platelet Aggregation Procedure: Blood Draw Phase 1

Study Type: Observational
Study Design: Time Perspective: Prospective
Official Title: Phase 1 Study to Determine Racial and Gender Differences in Platelet Aggregation

Further study details as provided by Texas Tech University Health Sciences Center:

Estimated Enrollment: 60
Study Start Date: May 2005
Study Completion Date: May 2006
Primary Completion Date: May 2006 (Final data collection date for primary outcome measure)
Detailed Description:

Genetic variability of various components of the coagulation system has been reported. Data on racial and gender differences in platelet aggregation are lacking.

We hypothesize that there are significant racial and gender differences on aggregatory response of platelets to commonly used agonists to evaluate platelet function such as adenosine diphosphate (ADP), epinephrine, collagen and arachidonic acid.

  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Race of Caucasian, African American, or Hispanic

Exclusion Criteria:

  • Chronic medical conditions
  • Tobacco use
  • Regular non-steroidal anti-inflammatory use, aspirin use, or use of one of the other anti-platelet drugs.
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00233428


Locations
United States, Texas
TTUHSC
Lubbock, Texas, United States, 79430
Sponsors and Collaborators
Texas Tech University Health Sciences Center
Investigators
Principal Investigator: Chanwit Roongsritong, MD TTUHSC
  More Information

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
ClinicalTrials.gov Identifier: NCT00233428     History of Changes
Other Study ID Numbers: L05-108
First Submitted: October 3, 2005
First Posted: October 5, 2005
Last Update Posted: May 12, 2015
Last Verified: May 2015

Keywords provided by Texas Tech University Health Sciences Center:
Healthy volunteers